missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human CCL3/CCL4 Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 8 publications
Brand: R&D Systems MAB270-500
This item is not returnable.
View return policy
Description
CCL3/CCL4 Monoclonal specifically detects CCL3/CCL4 in Human samples. It is validated for Western Blot, Neutralization, Immunocytochemistry.
Specifications
| CCL3/CCL4 | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| CCL3 | |
| E. coli-derived recombinant human CCL3/MIP-1 alpha Ala27-Ala92 Accession # P10147 | |
| 500 μg | |
| Primary | |
| Detects human CCL3/MIP-1 alpha in direct ELISAs and Western blots. In direct ELISAs, greater than 75% cross-reactivity with recombinant human (rh) CCL4/MIP-1 beta is observed while approximately 30% cross-reactivity with recombinant mouse (rm) CCL3, rmCCL4/MIP-1 beta , and rhCCL14 is observed. No cross-reactivity with rhCCL1, 2, 5, 7, 8, 11, 13, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, rmCCL1, 2, 5, 6, 7, 9/10/MIP-1 gamma , 11, 12, 17, 19, 20, 21, 22, 24, 25, or recombinant rat CCL20 is observed. | |
| Human | |
| Supernatant |
| Western Blot, Neutralization, Immunocytochemistry | |
| 93321 | |
| Western Blot 1 ug/mL, Neutralization 0.075-0.375 ug/mL, Immunocytochemistry 8-25 ug/mL | |
| P10147 | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 6348 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction